BRIEF published on 09/21/2026 at 19:05, 5 days 1 hour ago ABL Diagnostics Proposes Acquisition to Expand Global Reach International Expansion Molecular Diagnostics Healthcare Acquisition ABL Diagnostics Vela Diagnostics
PRESS RELEASE published on 09/21/2026 at 19:00, 5 days 1 hour ago Inside Information / Other news releases ABL Texcell Diagnostics announces proposed acquisition of Vela Diagnostics' activities in Singapore and the United States to strengthen international presence in molecular diagnostics Acquisition International Expansion Molecular Diagnostics ABL Texcell Diagnostics Vela Diagnostics
BRIEF published on 09/18/2026 at 20:05, 8 days ago ABL Texcell Diagnostics Reduces Resources in its Liquidity Contract Liquidity Contract INVEST SECURITIES Euronext Market Resource Reduction ABL Texcell Diagnostics
BRIEF published on 09/17/2026 at 20:05, 9 days ago ABL Diagnostics becomes ABL Texcell Diagnostics Euronext Paris Name Change Molecular Diagnostics Expansion Strategy Virology
BRIEF published on 09/17/2026 at 20:05, 9 days ago ABL Diagnostics Transitions to ABL Texcell Diagnostics Euronext Paris Molecular Diagnostics Corporate Rebranding Shareholder Decision ABL Texcell
PRESS RELEASE published on 09/17/2026 at 20:00, 9 days ago Inside Information / Other news releases ABL Diagnostics changes name to ABL Texcell Diagnostics. Shareholders decide to remain listed on Euronext Paris for long-term growth. New identity reflects growth in molecular diagnostics, virology, and life sciences Euronext Paris Life Sciences Molecular Diagnostics Virology ABL Texcell Diagnostics
BRIEF published on 09/14/2026 at 20:05, 12 days ago ABL Diagnostics Releases Latest Research Report Revenue Growth Profitability Financial Guidance Research Report ABL Diagnostics
PRESS RELEASE published on 09/14/2026 at 20:00, 12 days ago Inside Information / Other news releases ABL Diagnostics announces availability of the latest equity research report by All Invest Securities highlighting strong revenue growth and maintained target price of €8.7 per share Revenue Growth Target Price Equity Research Report ABL Diagnostics All Invest Securities
BRIEF published on 09/11/2026 at 12:06, 15 days 8 hours ago ABL Diagnostics Files Takeover Bid for IntegraGen Molecular Diagnostics Takeover Bid IntegraGen ABL Diagnostics Genomic Analysis
PRESS RELEASE published on 09/11/2026 at 12:01, 15 days 8 hours ago Inside Information / Operations of the issuer (acquisitions, sales...) ABL Diagnostics announces takeover bid for IntegraGen, a genomic analysis company. Acquisition subject to Commercial Court decision. ABLD focuses on molecular diagnostics solutions and growth strategy Growth Strategy Molecular Diagnostics Takeover Bid IntegraGen ABL Diagnostics
Published on 09/26/2026 at 01:00, 19 hours 53 minutes ago Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 19 hours 53 minutes ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 22 hours 38 minutes ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 1 day 3 hours ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 1 day 5 hours ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/26/2026 at 15:30, 5 hours 23 minutes ago QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 5 hours 38 minutes ago Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 13 hours 8 minutes ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/26/2026 at 00:01, 20 hours 52 minutes ago Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 1 day 2 hours ago 029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 17:40, 1 day 3 hours ago Availability of the 2026 half-year financial report
Published on 09/24/2026 at 18:00, 2 days 2 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 2 days 2 hours ago GUILLEMOT CORPORATION: 2026 CONSOLIDATED INTERIM RESULTS
Published on 09/24/2026 at 17:45, 2 days 3 hours ago Cegedim first-half 2026 results: profitability continues to improve
